Stryker Corporation (NYSE:SYK) Given Average Recommendation of “Moderate Buy” by Brokerages

Stryker Corporation (NYSE:SYK) has received an average rating of “Moderate Buy” from the nineteen research firms that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $427.50.

SYK has been the topic of a number of recent analyst reports. Piper Sandler reiterated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective on the stock in a report on Tuesday, January 6th. Sanford C. Bernstein upped their target price on Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research note on Friday, January 9th. UBS Group decreased their target price on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Finally, Citigroup reissued a “market outperform” rating on shares of Stryker in a research note on Friday, January 30th.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 5.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of SYK. Sankala Group LLC purchased a new position in shares of Stryker in the fourth quarter valued at approximately $26,000. Clayton Financial Group LLC purchased a new stake in shares of Stryker during the third quarter worth approximately $26,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Stryker during the second quarter worth approximately $28,000. Kilter Group LLC purchased a new position in Stryker in the 2nd quarter valued at $29,000. Finally, Howard Hughes Medical Institute purchased a new position in Stryker in the 2nd quarter valued at $29,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Stock Down 1.0%

SYK stock opened at $332.48 on Tuesday. Stryker has a one year low of $328.23 and a one year high of $404.87. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. The firm’s fifty day moving average is $362.68 and its 200 day moving average is $365.29. The firm has a market cap of $127.24 billion, a PE ratio of 39.58, a P/E/G ratio of 1.96 and a beta of 0.85.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter in the prior year, the firm posted $4.01 earnings per share. The company’s revenue was up 11.4% compared to the same quarter last year. On average, research analysts forecast that Stryker will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.